Lagergren Emily, Chihade Deena, Zhan Henry, Perez Sebastian, Brewster Luke, Arya Shipra, Jordan William D, Duwayri Yazan
Division of Vascular and Endovascular Surgery, Emory University, School of Medicine, Atlanta, GA.
Department of Surgery, Emory University, School of Medicine, Atlanta, GA.
Ann Vasc Surg. 2019 Jan;54:33-39. doi: 10.1016/j.avsg.2018.08.074. Epub 2018 Sep 20.
Endovascular aneurysm repair (EVAR) accounts for the majority of all abdominal aortic aneurysm (AAA) repairs in the United States. EVAR utilization in the aging population is increasing due to the minimally invasive nature of the procedure, the low associated perioperative morbidity, and early survival benefit over open repair. The objective of this study is to compare the outcomes of octogenarians after elective EVAR to their younger counterparts, a question that can be answered by a long-term, institutional data set.
This was a retrospective series of 255 patients, who underwent elective EVAR within our institution from 2008 to 2015. A comparative analysis of patients aged 80 years and older and less than 80 years was performed. Outcomes measured included perioperative death and myocardial infarction (MI), length of stay, and readmission within 30 days. Aneurysm reintervention, long-term surveillance imaging, and aneurysm-related deaths were also evaluated. In addition, subset analyses of octogenarians were compared for survival at 24 months.
Overall, 255 patients were included in our analysis. Fifty-nine patients were octogenarians, and 196 patients were nonoctogenarians. The mean age difference between the two groups was significant (84.5 years [SD, ±3.44] vs. 69.6 years [SD, ±6.13] in the ≥80 and <80 groups, respectively; P < 0.0001). There was no significant difference in the mean aneurysm size (6.03 cm [SD, ±1.12] vs. 5.535 cm [SD, ±0.9]; P < 0.06) between the ≥80 and < 80 groups. Octogenarians had higher rates of perioperative MI (5% vs. 1%, P < 0.04), thirty-day mortality (7% vs. 0%, P < 0.003), a higher number of perioperative complications (0.64 incidence per patient [SD, ±1.11] vs. 0.31 [SD, ±0.69], P < 0.005), and a longer mean hospital stay (5.34 [SD, ±5.75] days vs. 3.16 [SD, ±3.23] days, P < 0.0003), and they were also less likely to be discharged home after surgery (75% vs. 91%, P < 0.002). In the evaluated long-term outcomes, the two groups were similar with regard to aneurysm reintervention (10% vs. 9%, P < 0.06) and the stability of aneurysm sac size on imaging at last follow-up (71% vs. 80%, P < 0.27). The overall aortic related cause of death was different between the groups (8% vs. 1%, P < 0.003); however, the long-term aortic related mortality was not different between the two groups (2% vs. 1%, P < 0.4). Finally, a subset analysis of the octogenarian group was performed comparing patients based on survival status at 24 months. Higher preoperative creatinine (1.73 mg/dL [SD, ±1.54] vs. 1.15 mg/dL [SD, ±0.46]) and lower preoperative hematocrit (33.9% [SD, ±3.43] vs. 37.2% [SD, ±4.9]) along with number of perioperative complications (1.2 incidence per patient [SD, ±1.74] vs. 0.45 [SD, ±0.73]) were associated with death at 24 months after the index operation.
Elective endovascular repair of AAA in octogenarians carries a higher risk of perioperative mortality but acceptable long-term outcomes. Appropriateness of elective EVAR in octogenarians should be answered based on this potential short-lived survival benefit, taking into account that advanced age should not be the sole basis of exclusion for otherwise suitable candidates for elective EVAR.
在美国,血管内动脉瘤修复术(EVAR)占所有腹主动脉瘤(AAA)修复术的大部分。由于该手术具有微创性、围手术期发病率低以及相对于开放修复术具有早期生存获益,EVAR在老年人群中的应用正在增加。本研究的目的是比较择期EVAR术后八旬老人与年轻患者的结局,这一问题可通过长期的机构数据集来回答。
这是一项对255例患者的回顾性研究,这些患者于2008年至2015年在我们机构接受了择期EVAR。对年龄在80岁及以上和小于80岁的患者进行了比较分析。测量的结局包括围手术期死亡和心肌梗死(MI)、住院时间以及30天内再入院情况。还评估了动脉瘤再次干预、长期监测成像以及动脉瘤相关死亡情况。此外,对八旬老人亚组进行了24个月生存率的比较分析。
总体而言,255例患者纳入我们的分析。59例患者为八旬老人,196例患者为非八旬老人。两组之间的平均年龄差异显著(≥80岁组为84.5岁[标准差,±3.44],<80岁组为69.6岁[标准差,±6.13];P<0.0001)。≥80岁组与<80岁组之间的平均动脉瘤大小无显著差异(6.03 cm[标准差,±1.12] vs. 5.535 cm[标准差,±0.9];P<0.06)。八旬老人围手术期MI发生率较高(5% vs. 1%,P<0.04),30天死亡率较高(7% vs. 0%,P<0.003),围手术期并发症数量较多(每位患者发生率0.64[标准差,±1.11] vs. 0.31[标准差,±0.69],P<0.005),平均住院时间较长(5.34[标准差,±5.75]天 vs. 3.16[标准差,±3.23]天,P<0.0003),并且他们术后出院回家的可能性也较小(75% vs. 91%,P<0.002)。在评估的长期结局中,两组在动脉瘤再次干预方面相似(10% vs. 9%,P<0.06),且在最后一次随访时成像显示动脉瘤囊大小的稳定性方面相似(71% vs. 80%,P<0.27)。两组之间总体主动脉相关死因不同(8% vs. 1%,P<0.003);然而,两组之间长期主动脉相关死亡率无差异(2% vs. 1%,P<0.4)。最后,对八旬老人组进行了亚组分析,根据24个月时的生存状态对患者进行比较。术前肌酐水平较高(1.73 mg/dL[标准差,±1.54] vs. 1.15 mg/dL[标准差,±0.46])、术前血细胞比容较低(分别为33.9%[标准差,±3.43] vs. 37.2%[标准差,±4.9])以及围手术期并发症数量(每位患者发生率1.2[标准差,±1.74] vs. 0.45[标准差,±0.73])与首次手术后24个月的死亡相关。
八旬老人择期行AAA血管内修复术围手术期死亡风险较高,但长期结局可接受。八旬老人择期EVAR的适宜性应基于这种潜在的短期生存获益来确定,同时应考虑到高龄不应成为排除其他适合择期EVAR患者的唯一依据。